Impax Laboratories Inc (NASDAQ:IPXL)

49.25
Delayed Data
As of Jul 28
 0.00 / 0.00%
Today’s Change
22.12
Today|||52-Week Range
52.10
+55.46%
Year-to-Date

Today’s Trading

Previous close49.25
Today’s open49.63
Day’s range-- - --
Volume762,950
Average volume (3 months)770,564
Market cap$3.5B
Dividend yield--
Data as of 07/28/2015

Growth & Valuation

Earnings growth (last year)-44.90%
Earnings growth (this year)+6.83%
Earnings growth (next 5 years)+23.50%
Revenue growth (last year)+16.53%
P/E ratio77.6
Price/Sales3.75
Price/Book3.95

Competitors

 Today’s
change
Today’s
% change
CLVSClovis Oncology Inc+3.82+4.61%
INSYINSYS Therapeutics I...+1.61+3.76%
CBPOChina Biologic Produ...+4.61+4.03%
GRFSGrifols SA+0.04+0.13%
Data as of 07/28/2015

Financials

Next reporting dateAugust 10, 2015
EPS forecast (this quarter)$0.36
Annual revenue (last year)$596.0M
Annual profit (last year)$57.4M
Net profit margin9.62%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
George Frederick Wilkinson
Senior Vice President-
Global Operations
Andrew Schaschl
Corporate headquarters
Hayward, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers